XML 132 R104.htm IDEA: XBRL DOCUMENT v3.22.4
RESTATEMENT - Balance Sheet (Details) - USD ($)
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
RESTATEMENT            
Total assets $ 302,594,479 $ 84,264,830 $ 105,206,180 $ 45,413,291 $ 17,172,494  
Other financing costs - initial recognition of warrants at fair value   6,126,358 203,955,631 119,597,612    
Liability to issue shares 10,710,000       7,027,500  
Other   42,023,055 55,649,512 55,904,761 5,617,192  
Total liabilities 145,637,771 48,149,413 259,605,143 175,502,373 78,884,141  
Accumulated Deficit (889,907,455) (635,891,830) (631,044,679) (306,436,199) (150,374,649)  
Additional Paid-in Capital 947,765,155 671,508,553 476,344,845   88,650,286  
Others 98,259,819 498,694 300,871 176,347,117    
Total deficiency in shareholders' equity $ 156,956,709 36,115,417 (154,398,963) (130,089,082) $ (61,711,647) $ (42,504,019)
As Previously Reported            
RESTATEMENT            
Total assets   84,264,830 105,206,180 45,413,291    
Series E option liability   23,085,886        
Other   42,023,055 55,649,512 55,904,761    
Total liabilities   65,108,941 55,649,512 55,904,761    
Accumulated Deficit   (278,883,532) (219,411,972) (186,838,587)    
Additional Paid-in Capital   297,540,727 268,667,769      
Others   498,694 300,871 176,347,117    
Total deficiency in shareholders' equity   19,155,889 49,556,668 (10,491,470)    
Adjustments            
RESTATEMENT            
Series E option liability   (23,085,886)        
Other financing costs - initial recognition of warrants at fair value   6,126,358 203,955,631 119,597,612    
Total liabilities   (16,959,528) 203,955,631 119,597,612    
Accumulated Deficit   (357,008,298) (411,632,707) (119,597,612)    
Additional Paid-in Capital   373,967,826 207,677,076      
Total deficiency in shareholders' equity   $ 16,959,528 $ (203,955,631) $ (119,597,612)